$EYEN
Eyenovia Inc Stock $eyen

$eyen Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000114420418059318 Filed on November 13, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.060M	$1.830M	$310.0K
YoY Change	338.3%	490.32%
% of Gross Profit
Research & Development	$4.130M	$2.488M	$570.4K
YoY Change	144.38%	336.09%
% of Gross Profit
Depreciation & Amortization	$0.00	$10.00K	$0.00
YoY Change	-100.0%		-100.0%
% of Gross Profit
Operating Expenses	$6.180M	$4.320M	$885.3K
YoY Change	186.11%	388.02%
Operating Profit		-$4.320M	-$885.3K
YoY Change		388.02%
Interest Expense	$0.00	-$964.00	$665.00
YoY Change		-244.96%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$6.180M	-$4.320M	-$880.0K
YoY Change	186.11%	390.91%
Income Tax
% Of Pretax Income
Net Earnings	-$6.180M	-$4.321M	-$884.6K
YoY Change	186.11%	388.5%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$602.9K	-$430.7K	-$88.53K
COMMON SHARES
Basic Shares Outstanding	10.09M shares	9.999M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.73M	$21.04M	$7.410M
YoY Change	275.81%	183.94%
Cash & Equivalents	$19.73M	$21.04M	$7.406M
Short-Term Investments
Other Short-Term Assets	$130.0K	$300.0K	$130.0K
YoY Change	225.0%	130.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$19.86M	$21.34M	$7.540M
YoY Change	275.68%	183.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.74K	$11.15K	$30.00K
YoY Change	31.39%	-62.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$120.0K	$120.0K	$110.0K
YoY Change	-63.64%	9.09%
Total Long-Term Assets	$154.5K	$129.0K	$150.0K
YoY Change	-56.67%	-14.03%
TOTAL ASSETS
Total Short-Term Assets	$19.86M	$21.34M	$7.540M
Total Long-Term Assets	$154.5K	$129.0K	$150.0K
Total Assets	$20.02M	$21.47M	$7.690M
YoY Change	254.68%	179.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.510M	$840.2K	$320.0K
YoY Change	512.67%	162.57%
Accrued Expenses	$1.570M	$840.0K	$270.0K
YoY Change	423.33%	211.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.099M	$1.729M	$590.0K
YoY Change	460.73%	193.09%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$40.00K	$0.00	$6.410M
YoY Change		-100.0%
Total Long-Term Liabilities	$40.00K	$0.00	$6.410M
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.099M	$1.729M	$590.0K
Total Long-Term Liabilities	$40.00K	$0.00	$6.410M
Total Liabilities	$3.140M	$1.732M	$7.000M
YoY Change	468.25%	-75.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.51M	-$30.33M
YoY Change	89.57%
Common Stock	$1.147K	$1.009K
YoY Change	346.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.88M	$19.74M	$690.0K
YoY Change
Total Liabilities & Shareholders Equity	$20.02M	$21.47M	$7.690M
YoY Change	254.68%	179.21%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	-$6.180M	-$4.321M	-$884.6K
YoY Change	186.11%	388.5%
Depreciation, Depletion And Amortization	$0.00	$10.00K	$0.00
YoY Change	-100.0%		-100.0%
Cash From Operating Activities	-$4.100M	-$3.580M	-$830.0K
YoY Change	106.03%	331.33%	-63.44%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	$0.00	$10.00K
YoY Change	200.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$30.00K	$0.00	$10.00K
YoY Change	200.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.820M	60.00K	6.760M
YoY Change	-1862.5%	-99.11%	67.33%
NET CHANGE
Cash From Operating Activities	-4.100M	-3.580M	-830.0K
Cash From Investing Activities	-30.00K	0.000	10.00K
Cash From Financing Activities	2.820M	60.00K	6.760M
Net Change In Cash	-1.310M	-3.520M	5.940M
YoY Change	-39.35%	-159.26%	235.59%
FREE CASH FLOW
Cash From Operating Activities	-$4.100M	-$3.580M	-$830.0K
Capital Expenditures	-$30.00K	$0.00	$10.00K
Free Cash Flow	-$4.070M	-$3.580M	-$840.0K
YoY Change	105.56%	326.19%	-63.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q3	us-gaap	Cash Cash	21044135	USD
CY2017Q4	us-gaap	Cash Cash	5249511	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	298450	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37149	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	21342585	USD
	eyen	Payment Of Accrued Issuance Costs PaymentOfAccruedIssuanceCosts	-133000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2225118	shares
CY2017Q4	us-gaap	Assets Current AssetsCurrent	5286660	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11152	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27960	USD
CY2018Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	0	USD
CY2017Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	328700	USD
CY2018Q3	us-gaap	Assets Assets	21471537	USD
CY2017Q4	us-gaap	Assets Assets	5643320	USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	1009	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	257	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	50070169	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24351138	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30331187	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19261186	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	19739991	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	5090673	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21471537	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5643320	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6324616	shares
CY2018Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	24500000	USD
CY2018Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	20794135	USD
CY2017Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4999511	USD
CY2018Q3	eyen	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	103502	USD
CY2017Q4	eyen	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	28932	USD
CY2018Q3	eyen	Prepaid Patent Expense PrepaidPatentExpense	16489	USD
CY2017Q4	eyen	Prepaid Patent Expense PrepaidPatentExpense	7833	USD
CY2018Q3	us-gaap	Prepaid Insurance PrepaidInsurance	132563	USD
CY2017Q4	us-gaap	Prepaid Insurance PrepaidInsurance	384	USD
CY2018Q3	eyen	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	148020	USD
CY2017Q4	eyen	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	120455	USD
CY2018Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	132306	USD
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	0	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6400	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	41831	USD
CY2018Q3	us-gaap	Accrued Rent Current AccruedRentCurrent	12469	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2487573	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	570422	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6993832	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2233193	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1832794	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	314859	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4079249	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	735759	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	4320367	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	885281	USD
	us-gaap	Operating Expenses OperatingExpenses	11073081	USD
	us-gaap	Operating Expenses OperatingExpenses	2968952	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4320367	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-885281	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11073081	USD
	eyen	Payment Of Accrued Issuance Costs PaymentOfAccruedIssuanceCosts	0	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2968952	USD
CY2018Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-964	USD
CY2017Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	665	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3080	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1396	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-4321331	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-884616	USD
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.43
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.20
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2018Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10030296	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8514906	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9219818	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8514906	shares
CY2017Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	0	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9222	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1134	USD
CY2018Q3	eyen	Accrued Expenses And Other Liabilities Currents AccruedExpensesAndOtherLiabilitiesCurrents	888984	USD
CY2017Q4	eyen	Accrued Expenses And Other Liabilities Currents AccruedExpensesAndOtherLiabilitiesCurrents	306263	USD
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1100000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11070001	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2967556	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16808	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12336	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1115034	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	212411	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	261301	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	132506	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	593846	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	19601	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	715721	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	117734	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9005361	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2737980	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3262	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3262	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25089000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	345497	USD
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	81237	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24799985	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6759988	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	15794624	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4018746	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5249511	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3387288	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21044135	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7406034	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	470	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	30	USD
	eyen	Reduction In Additional Paid In Capitalstock Issuance Costs ReductionInAdditionalPaidInCapitalstockIssuanceCosts	-195700	USD
	eyen	Reduction In Additional Paid In Capitalstock Issuance Costs ReductionInAdditionalPaidInCapitalstockIssuanceCosts	0	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y3M18D
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2903941	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1684416	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2225118	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.03
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.68
CY2018Q3	eyen	Accrued Offering Costs AccruedOfferingCosts	0	USD
CY2017Q4	eyen	Accrued Offering Costs AccruedOfferingCosts	133000	USD
CY2018Q3	eyen	Credit Card Payable CreditCardPayable	40156	USD
CY2017Q4	eyen	Credit Card Payable CreditCardPayable	9843	USD
CY2018Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	350000	USD
CY2017Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	0	USD
CY2018Q3	eyen	Minority Interest Ownership Percentage In Company MinorityInterestOwnershipPercentageInCompany	0.05	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	569667	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1181926	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.68
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.95
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3913082	USD
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6000000	shares
CY2018Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	4702116	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	1412700
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P36M
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	175668	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.72
CY2018Q3	us-gaap	Security Deposit SecurityDeposit	117800	USD
CY2017Q4	us-gaap	Security Deposit SecurityDeposit	0	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1729214	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	552647	USD
CY2018Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2332	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2018Q3	us-gaap	Liabilities Liabilities	1731546	USD
CY2017Q4	us-gaap	Liabilities Liabilities	552647	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	840230	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	246384	USD
CY2018Q3	eyen	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	888984	USD
CY2017Q4	eyen	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	306263	USD
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6000000	shares
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6000000	shares
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10088996	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2566530	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10088996	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2566530	shares
	eyen	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	2332	USD
	eyen	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	56482	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	431574	USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	6409651	USD
	eyen	Accrual Of Deferred Offering Cost AccrualOfDeferredOfferingCost	0	USD
	eyen	Accrual Of Deferred Offering Cost AccrualOfDeferredOfferingCost	33000	USD
CY2018Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-3.75
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Reclassifications</div></div></div><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: "times new roman", times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Certain prior period balances have been reclassified in order to conform to current period presentation. These reclassifications have no effect on previously reported results of operations or loss per share.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q3	eyen	Prepaid Marketing Expenses PrepaidMarketingExpenses	24000	USD
CY2017Q4	eyen	Prepaid Marketing Expenses PrepaidMarketingExpenses	0	USD
CY2018Q3	eyen	Prepaid Rent And Security Deposit PrepaidRentAndSecurityDeposit	21896	USD
CY2017Q4	eyen	Prepaid Rent And Security Deposit PrepaidRentAndSecurityDeposit	0	USD
CY2018Q3	us-gaap	Net Rentable Area NetRentableArea	3800	sqft
CY2018Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1290000	USD
CY2018Q3	us-gaap	Security Deposit SecurityDeposit	118000	USD
CY2018Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	8000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	9000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	32000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	28965	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.95
CY2016Q3	us-gaap	Payments For Rent PaymentsForRent	3000	USD
CY2018Q1	us-gaap	Payments For Rent PaymentsForRent	4000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	27000	USD
CY2018Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1181926	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y3M18D
CY2018Q3	us-gaap	Share Based Compensation ShareBasedCompensation	462945	USD
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	206021	USD
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4451796	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	vest over three years from the date of grant with one-third vesting on the one-year anniversary of the date of grant and the balance vesting monthly over the remaining 24 months
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	20165	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	393999	shares
CY2018Q3	eyen	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	2230000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.66
CY2017Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.84
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.84
CY2018Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2225118	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	125000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27300000	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2211000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	EYENOVIA, INC.
	dei	Entity Central Index Key EntityCentralIndexKey	0001682639
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Trading Symbol TradingSymbol	EYEN
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10088996	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Small Business EntitySmallBusiness	true
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-117800	USD
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	0	USD
CY2018Q3	eyen	Accrued Legal Settlement Current AccruedLegalSettlementCurrent	150000	USD
CY2017Q4	eyen	Accrued Legal Settlement Current AccruedLegalSettlementCurrent	0	USD
CY2018Q3	eyen	Accrued Legal Expenses Current AccruedLegalExpensesCurrent	40411	USD
CY2017Q4	eyen	Accrued Legal Expenses Current AccruedLegalExpensesCurrent	0	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	98167	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	238300	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	244853	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	251586	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	258505	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	198156	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1289567	USD
CY2018Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2023-09-30
	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	150000	USD
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	61875	shares
CY2018Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.04
	eyen	Exercise Of Warrants On A Cashless Basis ExerciseOfWarrantsOnACashlessBasis	6	USD
	eyen	Exercise Of Warrants On A Cashless Basis ExerciseOfWarrantsOnACashlessBasis	0	USD
	us-gaap	Malpractice Loss Contingency Insurance Recoveries MalpracticeLossContingencyInsuranceRecoveries	10000000	USD
	us-gaap	Malpractice Loss Contingency Claims Incurred In Period MalpracticeLossContingencyClaimsIncurredInPeriod	450000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0274	pure
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0295	pure
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0189	pure
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0239	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0269	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0295	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0189	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0239	pure
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.41	pure
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.3	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.3	pure
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00000	pure
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00000	pure

Files In Submission

Name	View Source	Status
0001144204-18-059318-index-headers.html	Edgar Link	pending
0001144204-18-059318-index.html	Edgar Link	pending
0001144204-18-059318.txt	Edgar Link	pending
0001144204-18-059318-xbrl.zip	Edgar Link	pending
eyen-20180930.xml	Edgar Link	completed
eyen-20180930.xsd	Edgar Link	pending
eyen-20180930_cal.xml	Edgar Link	unprocessable
eyen-20180930_def.xml	Edgar Link	unprocessable
eyen-20180930_lab.xml	Edgar Link	unprocessable
eyen-20180930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv505711_10q.htm	Edgar Link	pending
tv505711_ex31-1.htm	Edgar Link	pending
tv505711_ex31-2.htm	Edgar Link	pending
tv505711_ex32-1.htm	Edgar Link	pending
tv505711_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EYEN
Eyenovia Inc Stock $eyen

2018 Q4 Form 10-Q Financial Statement

#000114420418059318 Filed on November 13, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EYEN Eyenovia Inc Stock $eyen

2018 Q4 Form 10-Q Financial Statement

#000114420418059318 Filed on November 13, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EYEN
Eyenovia Inc Stock $eyen